Ppt on prefilled syringes

Influenza and Shingles Vaccines August 2013

flu vaccination programme to children (2 to 16 years of age inclusive) - use of Fluenz® Fluenz® presentation: Prefilled nasal applicator-ready to use, no reconstitution or dilution required; Nasal spray (suspension); Each applicator contains 0.2ml. Colourless/(2 to 16 years of age inclusive) - use of inactivated flu vaccine Presentation: Inactivated flu vaccines are supplied as prefilled syringes; Must be shaken well before they are administered. Storage: Store between +2°C and +8°C, in original packaging/


ORTOBRAND young, dynamic and independent company specialized in manufactures and distributes  products are based on hyaluronic acid (HA),used for the.

of effects Up to 6 months Administration 1-3 intra - articular injection- 1 per week Packaging 2ml prefilled syringe in medical blister 30 mg/2 ml sodium hyaluronate Sterilization Autoclave Shelf life 3 year Storage Between +2 and/ Pain relief , mobility improvement, cartilage repair. Duration of effects 1 year Administration 1 injection/treatment Packaging 3ml prefilled syringe in medical blister 60mg/3ml (2%) sodium hyaluronate 90mg/3ml chondroitin sulfate Sterilization Autoclave Shelf life 3 year /


Preventing Vaccine Errors in the Real World: Providing Better Protection to Prevent Vaccine Preventable Diseases Cindy Schulte, RN, BSN VPD Surveillance.

stock, using the vaccine with the shortest expiration date first  Do NOT store vaccines in the door or crisper drawers of the refrigerator or on door of the freezer 9 Prefilling SyringesPrefilling syringes is strongly discouraged by CDC  May result in vaccine administration errors and waste  May consider in situations of heavy use of a single vaccine  Consider using manufacturer-supplied/


Copyright © 2010 Delmar, Cengage Learning. ALL RIGHTS RESERVED. Chapter 1 Relative Value, Addition, and Subtraction of Decimals.

common Copyright © 2010 Delmar, Cengage Learning. ALL RIGHTS RESERVED. Packaging Parenteral medications available in ampules, vials, prefilled syringes, bag solutions, and bottled solutions Copyright © 2010 Delmar, Cengage Learning. ALL RIGHTS RESERVED. IM Solutions / Delmar, Cengage Learning. ALL RIGHTS RESERVED. Example 3 Prescription for morphine sulfate 2 mg IV Morphine sulfate prefilled syringe contains 4 mg/mL How many mL should be administered intravenously? Copyright © 2010 Delmar, Cengage Learning. /


I NFLUENZA V ACCINATION P OLICIES AND P ROCEDURES Indiana State Department of Health November 2009.

November 2009 G LOSSARY Multi dose Vial (MDV): 5mL vial contains at least 10.5mL doses of vaccine Prefilled Syringes (PFS): Syringes arrive prefilled with vaccine for either.25mL or.5mL dose Intranasal: Nasal spray vaccine Vaccine presentation: MDV, PFS or Intranasal/for the short term storage at a clinic site. 9 V ACCINE S PECIFIC C ONSIDERATIONS LAIV Refrigerator storage Prefilled syringes Once needle attached, must use same day All inactivated vaccines Do not freeze or expose to freezing temperatures /


RxNorm Overview John Kilbourne MD National Library of Medicine kilbourj@mail.nlm.nih.gov.

337 IN 9237 MIN 3848 PIN 2184 “One-to-many” issues Adenosine 3 MG/ML Injectable Solution Adenosine 3 MG/ML Prefilled Syringe 1 ML Adenosine 3 MG/ML Prefilled Syringe 2 ML Adenosine 3 MG/ML Prefilled Syringe 4 ML Adenosine 3 MG/ML Prefilled Syringe Wrap-up RxNorm is derived from other drug data Drug classes, devices, radiopharmaceuticals out of scope Endorsed and used by CMS/


Influenza A (H1N1). Influenza is usually a respiratory infection Transmission  Regular person-to-person transmission  Primarily through contact with.

0.5 mL Age MedImmune (nasal spray) Live virus 0.2 mL (nasal spray sprayer) 02-49 yrs b Sanofi (IM) a Inactivated 0.25 mL prefilled syringe 0.5 mL prefilled syringe 5 mL multidose vial 0 0 25 6-35 mos b > 36 mos b > 6 mos b Novartis (IM) a 5 mL multidose vial 0.5/ mL prefilled syringe 25 < 1.0 ≥ 4 yrs b > 4 yrs b CSL Biotherapies, Inc (IM) a 0.5 mL prefilled syringe 5.0 mL multidose vial 0 24.5> 18 yrs 0.5 mL doses contain 15 µg hemagglutinin of /


OCTOBER 22, 2009 LEDESMA HALL LEONID ZAMORA MD MEDICAL GRANDROUNDS.

0.5 mL Age MedImmune (nasal spray) Live virus 0.2 mL (nasal spray sprayer) 02-49 yrs b Sanofi (IM) a Inactivated 0.25 mL prefilled syringe 0.5 mL prefilled syringe 5 mL multidose vial 0 0 25 6-35 mos b > 36 mos b > 6 mos b Novartis (IM) a 5 mL multidose vial 0.5/ mL prefilled syringe 25 < 1.0 ≥ 4 yrs b > 4 yrs b CSL Biotherapies, Inc (IM) a 0.5 mL prefilled syringe 5.0 mL multidose vial 0 24.5> 18 yrs 0.5 mL doses contain 15 µg hemagglutinin of /


EMA BENEPALI® BARRY Binta BOUVET Audrey BRICAUD Manon DAVROUX Clémence DELPLANQUE Margot DROUGARD Sixtine HIA Cécile LEFEBVRE Laurine MAUGEST Mathilde.

low dose, representing the human clinical dose) or 15 mg/kg (high dose) of SB4 or EU Enbrel (or US Enbrel®) in prefilled syringes, administered via bolus injection subcutaneously twice weekly on Days 1, 4, 8, 11, 15, 18, 22, and 25. 49 TOXICOLOGY/ Clinical 89 POST-MARKETING 90 RISK MANAGEMENT PLAN Prescribe the product on the correct and safe use of the pre-filled pen/prefilled syringes Inform them that the product is not for paediatric use Patient Alert Card which is to be given to patients using Benepali®/


New York State Center of Excellence in Bioinformatics & Life Sciences R T U New York State Center of Excellence in Bioinformatics & Life Sciences R T U.

Sympathomimetic agent (product) Epinephrine preparation Parenteral form epinephrine Adrenaline 1:10,000 100micrograms/1mL prefilled syringe Has dose form Injection (product) Allergen class Drug allergen Sympathomimetic agent (substance) Respiratory / John Doe’s medication #72566 Drug administration act #125611 Adrenaline 1:10,000 100micrograms/1mL prefilled syringe Described_by_means_of Injection (procedure) Described_by_means_of Patient (person) Described_by_ means_of New York State Center of Excellence/


Importance of Meningococcal Disease and Its Prevention David R. Johnson, MD, MPH Vice President and Regional Medical Expert Sanofi Pasteur Medical Affairs.

Conjugate Vaccines Manu- facturer VaccineActive Constiuents / AdjuvantPresentation BaxterNeisVac 10 μg C; TT / 10 μg C; TT / Al(OH) 3 prefilled syringe NovartisMenjugate 10 / 10 μg C; CRM 197 / Al(OH) 3 freeze-dried vial PfizerMeningtec 10 / 10 μg C; CRM 197/ Vaccines Manu- facturer VaccineActive Constiuents / AdjuvantPresentation BaxterNeisVac 10 μg C; TT / 10 μg C; TT / Al(OH) 3 prefilled syringe NovartisMenjugate 10 / 10 μg C; CRM 197 / Al(OH) 3 freeze-dried vial PfizerMeningtec 10 / 10 μg C; CRM/


“Refuse to infuse” Injection Safety for Infection Prevention “Refuse to infuse” Injection Safety for Infection Prevention 2011 Puget Sound APIC Conference.

one patient. Single use med vials are used for only one patient. CMS expectations Manufactured prefilled syringes are used for only one patient. Manufactured prefilled syringes are used for only one patient. Bags of IV solutions are used for only one patient/ for preparing and administering meds Failure to follow basic infection safety for preparing and administering meds Mistaken beliefs about syringe reuse “But I can prevent of infection transmission by…” “But I can prevent of infection transmission by…” /


H1N1 Vaccinations by Ohio EMS Personnel

can be used through the last day of the month indicated by the expiration date unless otherwise stated on package labeling -Expired vaccine should never be used Vaccine Preparation Prefilling Syringes -Do not fill syringes in advance due to the increased risk of administration and other errors -Medication administration guidelines state that the individual who administers a medication should be the one to/


Diabetic Care Provider Training © A Level III Course.

NPH  Long-acting - Glargine (Lantus) Storage:  Refrigeration or store at room temperature as specified by the manufacturer Delivery Methods  Insulin Syringe  Insulin Pen  Insulin Pump  Jet Injector When to Give Insulin Administer as specified by IHP, based on the doctor’s orders / and dispose of syringe Remove needle and dispose of syringe DO NOT RECAP NEEDLE! DO NOT RECAP NEEDLE! Insulin Pen: Devices Reusable (cartridge) pens Reusable (cartridge) pens Prefilled pens Prefilled pens Techniques for dose/


Western Health and Social Care Trust Epilepsy Emergency Medication Presentation Kerrie Kerrigan: Paediatric Epilepsy Nurse Maura Mackie : Paediatric Epilepsy.

and Social Care Trust Administration of Midazolam using the buccal route  Remove cap from prefilled syringe. If using midazolam solution draw up prescribed amount.  Insert the syringe into the space between the inside of the cheek and the teeth (Buccal cavity/ Administration of Midazolam using the intranasal route Remove cap from prefilled syringe or if using midazolam solution, draw up prescribed amount. Gently insert the tip of the syringe into the entrance of one nostril. Slowly push plunger, dripping/


Epinephrine Administration by the EMT Pilot Project for the Administration of Epinephrine by Washington EMTs Tamara Coulter BS, FF/PM Captain/MSO Steven.

response to the medication Both positive and negative Both positive and negative Kinds of Parenteral Drug Containers Glass ampules Glass ampules Single and multidose vials Single and multidose vials Nonconstituted syringes Nonconstituted syringes Prefilled syringes Prefilled syringes Intravenous medication fluids Intravenous medication fluids Ampules Vials Ampules and Vials Information on Drug Labels Name of medication Name of medication Expiration date Expiration date Total dose and concentration/


Routes of Drug Administration and Dosage Formulations

of Parenteral Dosage Forms Administration of Insulin – most commonly used medication that is administered subcutaneously is insulin. Insulin Product Selection – syringe size, needle length and needle gauge. Insulin vials are 10mL (containing 1,000 units of insulin); prefilled syringes contain 3mL. Insulin vials – Syringes sizes 0.3mL, 0.5mL, 1mL; size is determined by dose of insulin; insulin vials should never be shaken. Insulin/


Chapter 7 Routes & Formulations. Factors Influencing the Route of Administration Drugs are contained in dosing units called formulations or dosage forms.

dispersed by shaking. Coalescence is irreversible separation of the dispersed phase. Coalescence is irreversible separation of the dispersed phase. Other Delivery Systems Unit dose disposable syringes are prefilled syringes that contain a single premeasured dose of medication and are thrown away after use. Unit dose disposable syringes are prefilled syringes that contain a single premeasured dose of medication and are thrown away after use. An oral/


1 Copyright © 2011, 2007, 2003, 1999 by Saunders, an imprint of Elsevier Inc. All rights reserved. Administering Medications Chapter 35.

Parenteral medications must be sterile and in liquid form.  Are manufactured in ampules, single-dose or multidose vials, prefilled syringes, or cartridge systems.  Before dispensing, check expiration date and examine solution for possible deterioration.  Drug characteristics/ © 2011, 2007, 2003, 1999 by Saunders, an imprint of Elsevier Inc. All rights reserved. Parenteral Administration: Prefilled Cartridge Systems 31 Copyright © 2011, 2007, 2003, 1999 by Saunders, an imprint of Elsevier Inc. All rights /


Vaccination Training for Health Care Providers Betsy Hubbard, RN, MN Immunization Clinical Practice Supervisor Colleen Woolsey PhD, ARNP, MSN H1N1 Flu.

illness, with or without fever History of *GBS within 6 weeks after a previous flu shot. Flu Vaccine Formulations Seasonal flu vaccine Trivalent inactivated influenza vaccine (TIV) Ten-dose vial Prefilled syringe 0.25 ml and 0.5 ml Live attenuated influenza vaccine (LAIV) Novel H1N1 –monovalent versions of the same formulations Age range for vaccines and formulations differs by manufacturer Flu/


Deep Vein Thrombosis. Physical Examination GEN Somewhat overweight, Caucasian man who appears comfortable. Cooperative, A & O x 3, normal affect. VS BP.

ideal dose would be 88 mg every 12 hours, which would be rounded to 90 mg for practical purposes. Unfortunately, enoxaparinis not marketed in 90-mg prefilled syringes; it is available in 80- and 100-mg prefilled syringes. One must therefore choose either to round the dose up or down or to have the patient (or caregiver) expel 10 mg from a 100-mg/


Medication Safety Lizabeth Martin, MD Faculty Fellowship: Safety and Quality Mentors: Lynn Martin and Sally Rampersad.

administering Infusion 2 provider check “D-C-W-D-C” ICU hand-offs Provider handoffs New infusion in OR High Risk medications Countermeasure 3: Prefilled syringes and dispensary Pre-prepared syringes Level 5 error proofing Standard dilution and syringes sizes Less waste Dispensary One piece flow-obtain medications Obtain or “pre-pick” medications from secure room Emergency trays only in cart Improve efficiency, waste/


Parenterals Chapter 8. Parenterals Packaged as two general types of product: Packaged as two general types of product: Large Volume Parenteral Solutions.

of intravenous solutions. Typically large bags containing large volumes of intravenous solutions. Small Volume Parenteral Solutions (SVP) Small Volume Parenteral Solutions (SVP) Generally contained in ampules, vials, prefilled syringes & piggybacks. Generally contained in ampules, vials, prefilled syringes & piggybacks. Must be sterile, free of particulate matter, pyrogen free, because it is injected directly into the blood stream. Must be sterile, free of particulate matter, pyrogen/


1 ACIP Influenza Vaccine Recommendations 2013-14 Season Carolyn B. Bridges, MD, FACP Associate Director of Adult Immunizations ISD, NCIRD, CDC National.

and recommendations Fluarix® Quadrivalent (IIV4) 10 GlaxoSmithKline Approved for persons aged 3 years and older Available in 0.5mL prefilled syringes for IM injection Both Fluarix® (IIV3) and Fluarix® Quadrivalent (IIV4) available Likely more IIV3 available than IIV4 / for persons aged 18 and older Vaccine virus propagated in Madin Darby Canine Kidney cells Available in 0.5mL prefilled syringes for IM injection Vaccine viruses for ccIIV are not propagated in eggs; however, initial reference strains have been/


Immunotherapy to treat chronic illness

– 40 mg Qweek if no MTX P - 80 mg x1, then 40 mg following week 1st dose by health care professional Pen or prefilled syringe Remicade® (infliximab) Indications – RA, C/UC, PA, P, AS Crohn’s - effective in fistulizing disease IV infusion over 2 hours/SQ weekly P - Twice weekly for 3 months, then weekly RA – 25 mg 2x/week or 50 mg SQ weekly Autoinjector, prefilled syringe, Multiple use vial Shorter t1/2 than mAbs Quick onset of action Quick identification of intolerance Cimzia® (certolizumab pegol) C, RA /


1 Second semester 15 - 16 Chapter 34 Parenteral Medications Bader A. EL Safadi BSN, MSc Fundamental of Nursing – B Parenteral Medications.

semester 15 - 16 Bader A. EL Safadi BSN, MSc Fundamental of Nursing – B Parenteral Medications Parenteral Administration Equipment Syringes: all syringes contain a barrel, a plunger, and a tip or hub Calibrated in milliliters (mL), cubic centimeters (cc), units /liquid, known as diluent, to a powdered substance Prefilled cartridges 11 Second semester 15 - 16 Bader A. EL Safadi BSN, MSc Fundamental of Nursing – B Parenteral Medications Ampule, Vial, and Prefilled Cartridge 12 Second semester 15 - 16 Bader A./


NUR 141: SKILL 22-6 ADMINISTERING INTRAVENOUS MEDICATION BY PIGGYBACK INTERMITTENT INFUSION SETS AND MINI-INFUSION PUMPS.

. Prepare medications for one patient at a time using aseptic technique. Check label of medication carefully with MAR or computer printout 2 times when preparing medication. Pharmacy prepares piggyback and prefilled syringes. You will prepare medication for Volutrol. 2. Take medication(s) to patient at correct time. Medications that require exact timing include stat, first time or loading doses, and one time/


Kenneth McCall, BSPharm, PharmD, CGP Associate Professor | UNE.

Intradermal 4. Fluzone Intramuscular Tips for a Ouch-Free Flu Shot Do not prepare the vaccine in front of the patient. Use a prefilled syringe or change the needle. Make sure the alcohol is dry before injecting. Ensure the patient’s arm is relaxed. Inject into the deltoid/2✓2 ✓3✓3 Flublok Fluzone Intradermal Quad ✓ Fluzone High-Dose ✓ 1.Multi-dose vials contain mercury. Single-dose prefilled syringes are mercury-free. 2.Estimated to contain <50 femtograms (5x10 -8 mcg) of total egg protein per 0.5 ml dose. 3/


PATIENT SAFETY UPDATE SEPTEMBER 2014 This presentation should be used in conjunction with the full publication: Patient Safety Update including the summary.

the temperature at which any fuel may catch fire. Nitrous oxide should be avoided, the FiO2 should be 0.21 and a 50ml syringe prefilled with saline should be at hand. Staff are required to think and act quickly in the event of an airway fire, and theatre-/ the temperature at which any fuel may catch fire. Nitrous oxide should be avoided, the FiO2 should be 0.21 and a 50ml syringe prefilled with saline should be at hand. Staff are required to think and act quickly in the event of an airway fire, and theatre-/


TRANSITION SERIES Topics for the Advanced EMT CHAPTER Advanced Skills for the AEMT 49.

Administration methods by container type: –Glass ampule –Single dose vial –Multi dose vial –Non-constituted drug vial –Prefilled syringe –IV piggyback Introduction Given the provision of EMS in many states, it is now being recognized that the /two vials, one containing a powdered medication and one containing a liquid mixing solution. Preparation of Medications (cont’d) Prefilled SyringeSyringe of medication that does not need to be drawn from another source. –Two components  Drug cartridge (glass or/


2011 Handbook Changes including “Catch Ups” Brief presentation.

al. Pediatr Infect Dis J 2009;28:S109–118. Synflorix  can be co administered with other vaccines available in NZ Packaging and storage of Synflorix  Packs of 10 No needles Prefilled syringes Store at 2–8°C Do not freeze 3-year shelf-life Protect from light Shake well before use GSK NZ. Synflorix  Data Sheet, 2010. Administration of/


Schedule Changes 2011. Outline Main changes to the schedule: 2011 Pneumococcal disease – Impact of pneumococcal vaccines – New PCV vaccines Synflorix.

al. Pediatr Infect Dis J 2009;28:S109–118. Synflorix  can be co administered with other vaccines available in NZ Packaging and storage of Synflorix  Packs of 10 No needles Prefilled syringes Store at 2–8°C Do not freeze 3-year shelf-life Protect from light Shake well before use GSK NZ. Synflorix  Data Sheet, 2010. Administration of/


School “Flu” Clinics 2013-2014 Arkansas Department of Health Northwest Region.

to persons 9 through 49 years of age Age Group Dosage LAIV- FluMist® Age: 2 years through 49 years Prefilled, single-use sprayer containing 0.2 mL of vaccine –If not simultaneously administered, FluMist can be administered 4 weeks/ : 0.5ml IM (Vaccinator assistants (physicians and nurses) may prefill syringes with vaccine preparing just enough vaccine to meet the clinic’s needs on an ongoing basis. Discard any vaccine- filled syringes after the clinic closes.) Injection Technique “Nursing 101” (#1) Determine/


RET 1024L Introduction to Respiratory Therapy Lab

use single-use medication vials Infection Control Specialized Equipment Handling Equipment Handling Procedure Humidifiers Whenever possible, prefilled, sterile disposable humidifiers should be used With reusable humidifiers, fluid reservoirs should be filled with/ Control Mechanical Needle Recapping Devices Infection Control Be careful !!! Infection Control Used Needles and Syringes Always dispose of sharps in an appropriate puncture-resistant container Infection Control Handling Laboratory Specimens /


POSITIVE CONTROL SAMPLES FOR PARENTERAL PRODUCT CLASSES ASTM F02 Committee on Barrier Packaging.

Lei. American Pharmaceutical Review. February 20, 2013. Container Closure Integrity Testing Method Development and Validation for Prefilled Syringes. PARENTERAL TARGET LEAK SIZES Study Details:  Used pipettes.  Full submersion and pressure cycling in microbial/ American Pharmaceutical Review. February 20, 2013. Container Closure Integrity Testing Method Development and Validation for Prefilled Syringes.  Naturally occurring defects and laser defects are susceptible to blockage when testing.  Solutes may/


To Err Is Human; Not To Err Is Better! Vaccination Errors and How to Prevent Them Deborah L. Wexler, MD Immunization Action Coalition

vaccine ahead of time for mass vaccination clinics. One place I work is using vaccines drawn from a multidose vial as much as a week before actually giving the vaccine.” Prefilling syringes? This practice is strongly discouraged by CDC May result in vaccine administration errors May consider in situations of heavy use of a single vaccine ( e.g., annual influenza clinic) Consider/


Depo-subQ in Uniject Overview and Update Increasing Community Access to Injectable Contraceptives September 30, 2009.

pharmacuetical and vaccine producers to encourage commercialization of key products in Uniject The Uniject device is a prefillable injection system developed by PATH in 1987 in response to WHO’s call for improved injection delivery /month injectable contraceptive Cyclofem. Contraception. 1997;56:310–304. Making Drugs Available in Uniject The complex realities of prefilled syringes Any change of primary packaging (even just vial size change) requires development investment and regulatory approval Uniject is /


Alice Guh, MD, MPH Division of Healthcare Quality Promotion Centers for Disease Control and Prevention November 3, 2012 Epidemiology and Prevention of.

and parenteral solutions  Key injection safety recommendations include:  Dedicate single dose vials for single patient use  Always use new syringe and needle to access medication vials  Avoid prefilling and storing batch-prepared syringes (outside of pharmacy setting)  Whenever possible, use commercially manufactured or pharmacy-prepared prefilled syringes (saline, heparin) Education  Education of healthcare personnel  Proper care/maintenance of catheter  Periodically assess adherence to recommended/


Hepatitis C virus treatment Heba Abd El-fattah Sabry Clinical pharmacist-heamatology Department Pharm D Student.

solid-organ transplant. Specific contraindications to either monotherapy or combination therapy. PEGASYS® (alfa-2a) October 2002 PEGASYS is supplied as  SC. injectable soln. in a vial (180mcg/1 ml )  SC. prefilled syringes (180mcg/0.5 ml ) PEGASYS and COPEGUS Dosing Recommendations DurationCOPEGUS Dose PEGASYS Dose Genotype 48 weeks 75 kg = 1200 mg 180 µgGenotype 1, 4 24 weeks800 mg180 µgGenotype 2, 3/


Endocrine Medication. PITUITARY MEDICATIONS A.Description – 1.Anterior pituitary gland: Secretes growth hormone (GH), thyroid-stimulating hormone (TSH),

lispro 75/25 are also available) – e.Mixtures of insulin in prefilled syringes should be kept in the refrigerator, where they will be stable for at least 1 week; prefilled syringes should be kept flat or with the needle in an upright position to/ 3Rationale: When preparing a mixture of Regular insulin with another insulin preparation, the Regular insulin should be drawn into the syringe first. This sequence will avoid contaminating the vial of Regular insulin with insulin of another type. Options 1, 2, and/


UK/ME/1014/0038 Date of preparation: October 2014 The MERIT™ Programme More Recent Pharmacological Therapies Meeting Educational Requirements, Improving.

October 2014 How to administer exenatide OW: injecting 57 4h. Put the cover back on the needle. Dispose of the syringe with the covered needle still attached, as instructed by your healthcare professional Bydureon 2mg powder and solvent for prolonged-release suspension /of preparation: October 2014 How to use the lixisenatide device Sanofi Diabetes. How to use your Lyxumia ® ▼ (lixisenatide) prefilled pen. 2013 59 About the lixisenatide deviceHow to attach a needle How to remove a needle UK/ME/1014/0038 Date/


Infections resulting from treatment in hospitals and health care service units are a major global healthcare problem Methicillin- resistant Staphylococcus.

CYSTOSCOPY PREP TRAY A sterile tray ideally designed to prepare the patient for Cystoscopy procedure. Contains pre-filled syringe, with Pedicat™ lubricant. Featuring; Tinted airtight transparent syringe protecting contents from light. Specially designed protective cap preserves sterility up until the time of use. Peniclamp/ Folded Gauze Dressings Antiseptic Lubricating Gel Antiseptic Sterile Solution Prefilled syringes with medicated solutions Prefilled syringes for Catheter Inflation THANK YOU The END


1 | Financial data as of May 2010 Medical Supplies.

Open Suction Enteral Feeding/ GI Urology Nursing Care 10 | Financial data as of May 2010 Needles & Syringes Sharps Disposal Prefilled Syringes/IV Access SharpSafety 11 | Financial data as of May 2010 Monitoring & OR OR Products Peri-natal / budget and schedule. Manufacturing Capabilities Injection Molding Extrusion Hydrogel Mixing and Formulation RF Welding Bottle/Syringe Filling Custom Converting Laminating Ultrasonic Welding Die Cutting Textile Converting Electrode Assembly Electronic PCB Assembly Suture/


Implementation of California’s Anti- thimerosal legislation Howard Backer, MD, MPH Chief, Immunization Branch California Department of Health Services.

sanofi Pasteur) rarerareNo MPSV4, multidose vials (sanofi Pasteur) infrequent in 2-3 yr rare single dose syringe and use of MCV4 California Department of Health Services Immunization Branch California Department of Health Services Immunization /Branch California Department of Health Services Immunization Branch California Department of Health Services Immunization Branch GSK Fluarix prefilled syringe (Dresden plant) Fluarix prefilled syringe (Dresden plant) –≤ 1.25 ug thimerosal/0.5 ml –Licensed ≥ 18 yrs of /


CMS Critical Access Hospital (CAH) CoPs Part 1 of 3.

can site you if you do not follow this. IV Push Medications Guidelines  Provide IV push medications in a ready to administer form  Use only commercially available or pharmacy prepared prefilled syringes of IV solutions to flush and lock vascular access devices  If available in a single dose vial then need to buy in single dose vial  Aseptic technique should be used/


Intravenous Therapy West Coast University Week 7

change both After 2-3 units TPN (PPN) change both q24h Change caps q blood draws NO LABEL – change both Blood drawing Access line with prefilled 10cc NS Flush Draw back 10cc blood in same syringe (discard) New syringes – draw up sample Change cap Flush with 10cc NS (heparin??) CVC Side Effects Phlebitis Infection Pheumothorax mechanical vs bacterial Infection Pheumothorax Superior vena cava/


Fulvestrant (Faslodex®) in advanced breast cancer: What the treatment guidelines say… 679113.011 Date of preparation: March 2015.

additional 500 mg dose is given 2 weeks after the initial dose Each 500 mg pack contains two prefilled syringes Each prefilled syringe contains fulvestrant 250 mg ER, oestrogen receptor 1. Faslodex SPC 17 Feb 2012. https://www.medicines.org/ relapse on or after adjuvant antioestrogen therapy or disease progression on therapy with an antioestrogen. Presentation A pre-filled syringe contains 250 mg fulvestrant in 5 ml solution. Safety needles (SafetyGlide™) are also provided. Dosage and administration Adult/


Faslodex ® (fulvestrant) in the treatment of metastatic breast cancer Prescribing information is available on the last slide 706832.011 March 2015.

dose is given 2 weeks after the initial dose Each pack of Faslodex 500 mg contains two prefilled syringes -Each prefilled syringe contains Faslodex 250 mg Faslodex is indicated for the treatment of post-menopausal women with oestrogen-receptor-/relapse on or after adjuvant antioestrogen therapy or disease progression on therapy with an antioestrogen. Presentation A pre-filled syringe contains 250 mg fulvestrant in 5 ml solution. Safety needles (SafetyGlide™) are also provided. Dosage and administration /


Copyright © 2015 Cengage Learning® Chapter 9 Parenteral Medication Labels and Dosage Calculation.

most common Intradermal 9-2 Copyright © 2015 Cengage Learning® Packaging Parenteral medications are available in ampules, vials, prefilled syringes, bag solutions, and bottled solutions. 9-3 Copyright © 2015 Cengage Learning® Labels of Parental Solutions The labels/formula: 9-15 Copyright © 2015 Cengage Learning® Example 3 Prescription for morphine sulfate 2 mg IV Morphine sulfate prefilled syringe contains 4 mg/mL How many mL should be administered intravenously? (continues) 9-16 Copyright © 2015 Cengage /


Copyright © 2015 Cengage Learning® Chapter 9 Parenteral Medication Labels and Dosage Calculation.

skin layer). 4 Copyright © 2015 Cengage Learning® 5 Packaging Parenteral medications are available in ampules, vials, prefilled syringes, bag solutions, and bottled solutions. 9-6 Copyright © 2015 Cengage Learning® Labels of Parental Solutions The /basic formula: 9-18 Copyright © 2015 Cengage Learning® Example 3 Prescription for morphine sulfate 2 mg IV Morphine sulfate prefilled syringe contains 4 mg/mL How many mL should be administered intravenously? (continues) 9-19 Copyright © 2015 Cengage Learning®/


Ads by Google